|
|
Neurology August 2009
Volume 73
Issue 8
| This week in Neurology(R) |
this week in neurology(r): highlights of the august 25 issue.
Pages: 575
|
| Editorials |
migraine and risk of cardiovascular disease in women: learning about relative and absolute risk.
- Diener, Hans-Christoph, Beck, Christopher. Pages: 576-577
|
multiple sclerosis: evidence of maternal effects and an increasing incidence in women.
- Rose, John. Pages: 578-579
|
| In Memoriam |
susan s. spencer, md (1948-2009).
- Berg, Anne, Vickrey, Barbara, MD, MPH. Pages: 580
|
| Articles |
migraine frequency and risk of cardiovascular disease in women symbol .
- Kurth, Tobias, MD, ScD, Schurks, Markus, MD, MSc, Logroscino, Giancarlo, MD, PhD, Buring, Julie. Pages: 581-588
>
Show/Hide Abstract
Background: Migraine has been associated with risk of cardiovascular disease (CVD). Data on the association between migraine frequency and CVD are sparse.Methods: Prospective cohort study of 27,798 US women aged >=45 years, who were free of CVD, and for whom we had information on lipids and migraine frequency. We categorized migraine frequency as < monthly, monthly, and >= weekly. Incident CVD was confirmed after medical record review.Results: Of the 3,568 women with active migraine at baseline, 75.3% reported a migraine frequency of < monthly, 19.7% monthly, and 5.0% >= weekly. During 11.9 years of follow-up, 706 CVD events occurred. Compared with women without migraine, the multivariable-adjusted hazard ratios (HRs) (95% confidence intervals) among active migraineurs for CVD were 1.55 (1.22-1.97), 0.65 (0.31-1.38), and 1.93 (0.86-4.33) for an attack frequency of < monthly, monthly, and >= weekly, respectively. The association between migraine frequency and CVD was only apparent among migraineurs with aura. Among those, the multivariable-adjusted HRs for women with a migraine frequency < monthly ranged from 1.81 (1.30-2.50) for coronary revascularizations to 2.43 (1.58-3.74) for myocardial infarction. For women with active migraine with aura and migraine frequencies of >= weekly, we only found significant increased risk of ischemic stroke (HR = 4.25 [1.36-13.29]).Conclusions: In our data, the association between migraine and cardiovascular disease varies by migraine frequency. Significant associations were only found among women with migraine with aura. Ischemic stroke was the only outcome associated with a high-attack frequency while a low-attack frequency was associated with any vascular event. Low number of outcome events should caution the interpretation.(C)2009AAN Enterprises, Inc.
|
association of higher diastolic blood pressure levels with cognitive impairment.
- Tsivgoulis, G, Alexandrov, A, Wadley, V, Unverzagt, F, Go, R, Moy, C, Kissela, B, Howard, G. Pages: 589-595
>
Show/Hide Abstract
Background: We evaluated the cross-sectional relationship of blood pressure (BP) components with cognitive impairment after adjusting for potential confounders.Methods: Reasons for Geographic and Racial Differences in Stroke (REGARDS) is a national, longitudinal population cohort evaluating stroke risk in 30,228 black and white men and women >=45 years old. During the in-home visit, BP measurements were taken as the average of 2 measurements using a standard aneroid sphygmomanometer. Excluding participants with prior stroke or TIA, the present analysis included 19,836 participants (enrolled from December 2003 to March 2007) with complete baseline physical and cognitive evaluations. Incremental logistic models examined baseline relationships between BP components (systolic blood pressure [SBP], diastolic blood pressure [DBP], and pulse pressure [PP]) and impaired cognitive status (score of <=4 on 6-Item Screener) after adjusting for demographic and environmental characteristics, cardiovascular risk factors, depressive symptoms, and current use of any antihypertensive medication.Results: Higher DBP levels were associated with impaired cognitive status after adjusting for demographic and environmental characteristics, risk factors, depressive symptoms, and antihypertensive medications. An increment of 10 mm Hg in DBP was associated with a 7% (95% confidence interval [CI] 1%-14%, p = 0.0275) higher odds of cognitive impairment. No independent association was identified between impaired cognitive status and SBP (odds ratio [OR] 1.02, 95% CI 0.99-1.06) or PP (OR 0.99, 95% CI 0.95-1.04). There was no evidence of nonlinear relationships between any of the BP components and impaired cognitive status. There was no interaction between age and the relationship of impaired cognitive status with SBP (p = 0.827), DBP (p = 0.133), or PP (p = 0.827) levels.Conclusions: Higher diastolic blood pressure was cross-sectionally and independently associated with impaired cognitive status in this large, geographically dispersed, race- and sex-balanced sample of stroke-free individuals.(C)2009AAN Enterprises, Inc.
|
cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes.
- Blumen, S, Bouchard, J, MD, FRCPC, Brais, B, MD, PhD, Carasso, R, Paleacu, D, Drory, V, Chantal, S, Blumen, N, Braverman, I. Pages: 596-601
>
Show/Hide Abstract
Objective: To assess the evolution and life expectancy in patients with oculopharyngeal muscular dystrophy (OPMD) who are homozygotes for two (GCN)13 expansions in the PABPN1 encoding gene.Background: OPMD is particularly frequent among French Canadians (FCs) and Uzbek Jews (UJs), who carry a same size, (GCN)13, PABPN1 mutation. The high rate of consanguinity among UJs together with late disease onset and normal fertility results in homozygous cases.Methods: For 15 to 20 years, we followed 4 FC and 6 UJ homozygotes with OPMD and compared them with their heterozygous parents and siblings. In addition to clinical evaluation, electrodiagnostic tests, psychological tests, and brain imaging studies were performed.Results: In all (GCN)13-(GCN)13 patients, OPMD started before age 35 years, with bilateral ptosis and dysphagia; external ophthalmoparesis and dysphonia followed within a few years, as well as weakness in proximal limb muscles. All patients had recurrent aspirations and lost weight; 4 patients required surgical interventions to alleviate dysphagia, and 5 required feeding gastrostomies. Most patients were followed by psychiatrists due to cognitive decline, recurrent depression, or psychotic episodes. Six patients died at ages 50, 51, 53, 56, 56, and 57 years. The eldest patient is now 51 years old; she is cachectic and requires special diet and psychiatric care for paranoid psychosis and uninhibited behavior.Conclusions: Oculopharyngeal muscular dystrophy progresses faster in homozygote compared with heterozygote patients. It is not restricted to the muscles, but also involves the CNS with cognitive decline and psychotic manifestations and leads to a reduced life expectancy.(C)2009AAN Enterprises, Inc.
|
parent-of-origin effect in multiple sclerosis: observations from interracial matings.
- Ramagopalan, S, Yee, I, Dyment, D, MD, DPhil, Orton, S, Marrie, R, MD, PhD, Sadovnick, A, Ebers, G, MD, FRCP, FRCPC, FMedSci. Pages: 602-605
>
Show/Hide Abstract
Background: Multiple sclerosis (MS) is a complex neurologic disease with a striking geographical distribution. In Canada, prevalence is high in Caucasians of Northern European ancestry and uncommon in North American Aboriginals, many of whom now have Caucasian admixture.Methods: The population-based Canadian Collaborative Project on the Genetic Susceptibility to MS provided the characteristics of 58 individuals with 1 Caucasian and 1 North American Aboriginal parent from a database of 30,000 MS index cases.Results: We found that MS index cases with a Caucasian mother and a North American Aboriginal father had a higher sib recurrence risk and greater F:M sex ratio (p = 0.043) than patients with a North American Aboriginal mother and Caucasian father.Conclusions: Maternal parent-of-origin effects in multiple sclerosis disease etiology previously seen in studies of half-siblings and avuncular pairs are also seen in Caucasian-North American Aboriginal admixture matings and warrant further investigation. A differential influence of maternal risk transmission on the sex ratio of affected offspring is implied. The method of analysis used may have broader implications for detection of parent-of-origin effects in admixture cohorts.(C)2009AAN Enterprises, Inc.
|
motor cortex and thalamic atrophy in unverricht-lundborg disease: voxel-based morphometric study.
- Koskenkorva, P, Khyuppenen, J, MD, PhD, Niskanen, E, Kononen, M, Bendel, P, Mervaala, E, MD, PhD, Lehesjoki, A, MD, PhD, Kalviainen, R, MD, PhD, Vanninen, R, MD, PhD. Pages: 606-611
>
Show/Hide Abstract
Objective: To evaluate possible changes in the gray matter volume of patients with Unverricht-Lundborg disease (EPM1) compared with healthy controls.Methods: Thirty-four genetically verified patients with EPM1 and 30 healthy controls matched for age and sex underwent MRI (T1-, T2-, fluid-attenuated inversion recovery-, and T1-weighted 3-dimensional images). T1-weighted 3-dimensional images were analyzed with voxel-based morphometry (VBM) to compare the regional differences in gray matter volumes between patients and controls. The patients with EPM1 were also clinically evaluated for myoclonus severity using the Unified Myoclonus Rating Scale.Results: VBM analysis revealed atrophy in the bilateral primary, premotor, and supplementary motor cortex. The thalamus and precuneus were also bilaterally affected. No infratentorial changes were detected in the group analysis.Conclusion: The cortical motor areas of the brain are particularly affected in EPM1, correlating with the motor symptoms of this disease. The combination of detailed imaging with neurophysiologic evaluation may help to reveal the pathogenesis of Unverricht-Lundborg disease.(C)2009AAN Enterprises, Inc.
|
semantic memory activation in individuals at risk for developing alzheimer disease.
- Seidenberg, M, Guidotti, L, Nielson, K, Woodard, J, Durgerian, S, Antuono, P, Zhang, Q, Rao, S. Pages: 612-620
>
Show/Hide Abstract
Objective: To determine whether whole-brain, event-related fMRI can distinguish healthy older adults with known Alzheimer disease (AD) risk factors (family history, APOE [varepsilon]4) from controls using a semantic memory task involving discrimination of famous from unfamiliar names.Methods: Sixty-nine cognitively asymptomatic adults were divided into 3 groups (n = 23 each) based on AD risk: 1) no family history, no [varepsilon]4 allele (control [CON]); 2) family history, no [varepsilon]4 allele (FH); and 3) family history and [varepsilon]4 allele (FH+[varepsilon]4). Separate hemodynamic response functions were extracted for famous and unfamiliar names using deconvolution analysis (correct trials only).Results: Cognitively intact older adults with AD risk factors (FH and FH+[varepsilon]4) exhibited greater activation in recognizing famous relative to unfamiliar names than a group without risk factors (CON), especially in the bilateral posterior cingulate/precuneus, bilateral temporoparietal junction, and bilateral prefrontal cortex. The increased activation was more apparent in the FH+[varepsilon]4 than in the FH group. Unlike the 2 at-risk groups, the control group demonstrated greater activation for unfamiliar than familiar names, predominately in the supplementary motor area, bilateral precentral, left inferior frontal, right insula, precuneus, and angular gyrus. These results could not be attributed to differences in demographic variables, cerebral atrophy, episodic memory performance, global cognitive functioning, activities of daily living, or depression.Conclusions: Results demonstrate that a low-effort, high-accuracy semantic memory activation task is sensitive to Alzheimer disease risk factors in a dose-related manner. This increased activation in at-risk individuals may reflect a compensatory brain response to support task performance in otherwise asymptomatic older adults.(C)2009AAN Enterprises, Inc.
|
essential tremor is associated with dementia: prospective population-based study in new york.
- Thawani, Sujata, Schupf, Nicole, Louis, Elan, MD, MSc. Pages: 621-625
>
Show/Hide Abstract
Background: Mild cognitive deficits, mainly in frontal-executive function and memory, have been reported in patients with essential tremor (ET). Furthermore, an association between ET and dementia has been reported in a single population-based study in Spain. This has not been confirmed elsewhere.Objective: To determine whether baseline ET is associated with prevalent and incident dementia in an ethnically diverse, community-based sample of elders.Methods: Community-dwelling elders in northern Manhattan were enrolled in a prospective cohort study. Baseline ET diagnoses were assigned from handwriting samples. Dementia was diagnosed at baseline and follow-up using DSM-III-R criteria.Results: In cross-sectional analyses, 31/124 (25.0%) ET cases had prevalent dementia vs 198/2,161 (9.2%) controls (odds ratio [OR]unadjusted = 3.31, 95% confidence interval [CI] = 2.15-5.09, p < 0.001; ORadjusted = 1.84, 95% CI = 1.13-2.98, p = 0.01). In prospective analyses, 17/93 (18.3%) ET cases vs 171/1,963 (8.7%) controls developed incident dementia (hazard ratio [HR]unadjusted = 2.78, 95% CI = 1.69-4.57, p < 0.001; HRadjusted = 1.64, 95% CI = 0.99-2.72, p = 0.055).Conclusions: In a second population-based study of elders, essential tremor (ET) was associated with both increased odds of prevalent dementia and increased risk of incident dementia. Presence of dementia, therefore, appeared to be greater than that expected for age (i.e., a disease-associated feature). Rather than attributing cognitive complaints in patients with ET to old age, assessment and possible treatment of dementia should be routinely incorporated into the treatment plan.(C)2009AAN Enterprises, Inc.
|
clinical heterogeneity in 3 unrelated families linked to vcp p.arg159his.
- van der Zee, J, Pirici, D, Van Langenhove, T, Engelborghs, S, MD, PhD, Vandenberghe, R, MD, PhD, Hoffmann, M, Pusswald, G, Van den Broeck, M, Peeters, K, Mattheijssens, M, Martin, J, MD, PhD, De Deyn, P, MD, PhD, Cruts, M, Haubenberger, D, Kumar-Singh, S, MD, PhD, Zimprich, A, Van Broeckhoven, C, PhD, DSc. Pages: 626-632
>
Show/Hide Abstract
Background: Families associated with missense mutations in the valosin-containing protein (VCP) present with a rare autosomal dominant multisystem disorder of frontotemporal lobar degeneration (FTLD), inclusion body myopathy (IBM), and Paget disease of bone (PDB), referred to as IBMPFD.Methods: We used exon-based genomic DNA sequencing to test for VCP mutations in 123 unrelated Belgian patients with FTLD and their relatives, and the absence of such mutations in 157 control individuals. We analyzed haplotype sharing among mutation carriers by genotyping 8 microsatellite markers in the VCP locus. We obtained family history and clinical and pathologic data using established diagnostic instruments.Results: Mutation analysis of VCP identified 2 Belgian patients with FTLD carrying the p.Arg159His mutation, which segregated in their families. In one family, patients presented with FTLD only, whereas in the other family, patients developed FTLD, PDB, or both without signs of IBM for any of the mutation carriers. We had previously identified p.Arg159His in an Austrian family with patients exhibiting both IBM and PDB. Haplotype sharing analysis indicated that the 3 p.Arg159His families are unrelated. Clinical follow-up of the Austrian family identified dementia symptoms in 1 patient. Autopsy data of 3 patients of the 2 Belgian families revealed FTLD pathology with numerous ubiquitin-immunoreactive, intranuclear inclusions and dystrophic neurites staining positive for TDP-43 protein.Conclusions: In 3 unrelated families with IBMPFD segregating VCP p.Arg159His, we observed a high degree of clinical heterogeneity and variable penetrance of the 3 cardinal clinical phenotypes: inclusion body myopathy, Paget disease of bone, and frontotemporal lobar degeneration. In contrast, the neuropathologic phenotype was consistent with FTLD-TDP type 4.(C)2009AAN Enterprises, Inc.
|
dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency.
- Porta, F, Mussa, A, Concolino, D, Spada, M, MD, PhD, Ponzone, A. Pages: 633-637
>
Show/Hide Abstract
Objective: To report the efficacy, tolerability, and safety of the dopamine agonist pramipexole in a series of 5 patients affected by inherited 6-pyruvoyl tetrahydropterin synthase (PTPS) deficiency and needing l-3,4 dihydroxyphenylalanine (l-dopa) therapy.Methods: Patients included 4 males and 1 female with ages ranging from 2 to 26 years. Their medication included tetrahydrobiopterin (BH4), 5-hydroxytryptophan, l-dopa, carbidopa, selegiline, and entacapone. All experienced residual symptoms of dopamine deficiency, movement and behavioral disability, and complications of l-dopa therapy, associated with fluctuating hyperprolactinemia. Patients had full assessment of clinical and biochemical condition, including evaluation by an adapted Unified Parkinson's Disease Rating Scale (UPDRS) and measurement of plasma prolactin (PRL) and catecholamines, before and after a 6-week trial with pramipexole. Pramipexole was administered twice daily as an adjunct to l-dopa therapy in dosages upwardly titrated, with a concurrent reduction of l-dopa dosage. Clinical follow-up went on for 1 year.Results: Pramipexole was well tolerated by all patients, with marked improvement and stabilization of their clinical picture. The mean improvement on the total UPDRS score was 43% (range 33.3%-55.6%) from baseline. Diurnal profiles of plasma PRL normalized and plasma catecholamine levels lasted unchanged. The daily administrations of l-dopa were curtailed from 3 or 4 to 2, and the l-dopa dosage was reduced up to 40%.Conclusions: The addition of pramipexole to the treatment of 6-pyruvoyl tetrahydropterin synthase deficiency improves the results of l-3,4 dihydroxyphenylalanine therapy. Similar benefits may be expected in other forms of inherited tetrahydrobiopterin deficiency.(C)2009AAN Enterprises, Inc.
|
vertigo as a migraine trigger.
- Murdin, Louisa, Davies, Rosalyn, MD, PhD, Bronstein, Adolfo, MD, PhD. Pages: 638-642
>
Show/Hide Abstract
Background: It is reported in some individual patients that vestibular stimuli can trigger migraine attacks. This study used a case-control design to examine systematically the hypothesis that vertigo induced by vestibular stimulation (rotation/caloric testing) can act as a specific migraine trigger.Methods: A total of 123 new patients attending neuro-otology or neurology clinics were studied with questionnaires and physician interview to ascertain migraine history according to International Headache Society criteria. A total of 79 who underwent rotation/caloric vestibular testing (test group) were compared with 44 control patients in whom no such testing was carried out (control group). The principal outcome measure was the occurrence of a migraine attack within 24 hours of exposure to vestibular stimulation.Results: Of those participants with a past history of migraines, 19/39 (49%) of the test group experienced a migraine in the study time window, compared with 1/21 (5%) of the control group. Binary logistic regression analysis confirmed that vestibular testing was associated (p < 0.05) with migraine attacks.Conclusions: The results indicate that induced vertigo can act as a migraine trigger, a finding with implications for the diagnosis of patients with episodic vertigo and migraine headache. While such patients may well have basilar migraine or migrainous vertigo, alternatively, another disorder causing episodic vertigo (e.g., benign paroxysmal positional vertigo or Meniere disease) may be triggering migraine headaches.(C)2009AAN Enterprises, Inc.
|
| Clinical/Scientific Notes |
restless legs syndrome with periodic limb movements: a possible cause of idiopathic hyperckemia.
- Della Marca, G, MD, PhD, Dittoni, S, Catteruccia, M, Frusciante, R, MD, PhD, Madia, F, MD, PhD, Losurdo, A, Testani, E, Vollono, C, MD, PhD, Servidei, S. Pages: 643-645
|
temporomandibular symptoms, migraine, and chronic daily headaches in the population.
- Goncalves, D, DDS, MSc, Speciali, J, MD, PhD, Jales, L, Camparis, C, DDS, MSc, Bigal, M, MD, PhD. Pages: 645-646
|
| NeuroImages |
reversible visual memory in transient splenial lesion.
- Jeong, Seong-Hae, Lee, Ji, Lee, Ae, Young MD, PhD. Pages: 647
|
| Resident & Fellow Section |
clinical reasoning: a 35-year-old man with a right hemiplegia and a cerebral mass.
- Moretta, G, Pettinicchi, J, Talarico, M, Lopez, P, Cerrato, S, Balbuena, M, Poderoso, J, Mazzocchi, O, Dal Verme, A, Menghi, C, Arcavi, M, Grecco, M, Ferreiro, J, MD, PhD. Pages: e35-e38
|
emerging subspecialties in neurology: translational research in movement disorders.
- Kuo, Sheng-Han, Jackson, George, MD, PhD. Pages: e40-e41
|
| Patient Page |
migraine frequency and risk of cardiovascular disease in women.
- Klein, Eve, Spencer, David. Pages: e42-e43
|
| Correspondence |
orthostatic headache without csf leak.
- Bono, Francesco, Quattrone, Aldo. Pages: 648
|
natural history of young-adult amyotrophic lateral sclerosis.
- Yoshii, Y, Hadano, S, Otomo, A, Suzuki, K, Ikeda, K, Ikeda, J, Iwasaki, Y. Pages: 648-650
|
| Departments: Book Review |
a practical approach to movement disorders: diagnosis and surgical and medical management.
- Goudreau, John, DO, PhD. Pages: 651
|
| Departments: Calendar |
calendar.
Pages: 652
|
| Future Issues |
in the next issue of neurology(r): volume 73, number 9, september 1, 2009.
Pages: A26
|
|
|